This year has seen sharp stock moves as companies report financial results and update investors on early and mid-stage drug studies ...

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to ...

Mark Cuban (entrepreneur, investor, and founder, Cost Plus Drugs) joins Chris Cuomo to discuss disrupting Big Pharma, ...

One company is determined to improve drug development success rates, and its cell simulation platform is already being used ...

If for no other reason than that it will elicit fear in the hearts of autocracy-phobics, I propose that Donald Trump’s second ...

Nobody is more expert or cares about your health more than you Not Big Pharma, not Big Food and certainly not Big Medicine ...

Krispy Kreme is rapidly expanding its U.S. presence, aiming for 26,000 access points by FY 2026. Find out why I prefer to ...

Naomi Wolf is a truly heroic figure, and the publication of her great book The Pfizer Papers: Pfizer’s Crimes Against ...

A cadre of health business leaders and nonmainstream doctors are influencing the next President's health policy.

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...